96 related articles for article (PubMed ID: 7812980)
1. Correlation between family history of colorectal cancer and pathological and clinical features of the disease.
Aste H; Picasso M; Allegretti A; Conio M
Cancer Detect Prev; 1994; 18(5):343-8. PubMed ID: 7812980
[TBL] [Abstract][Full Text] [Related]
2. [Colorectal adenocarcinoma in patients with familial anamnesis positive for malignant neoplasms of the large intestine].
Aste H; Picasso M; Allegretti A; Conio M
Epidemiol Prev; 1992 Jun; 14(51):25-9. PubMed ID: 1345012
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
5. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
6. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease.
Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A
Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293
[TBL] [Abstract][Full Text] [Related]
7. [Multivariate analysis of prognostic factors in colorectal cancer patients with different ages].
Cai SR; Zheng S; Zhang SZ
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):483-5. PubMed ID: 16188146
[TBL] [Abstract][Full Text] [Related]
8. Young age is not a poor prognostic marker in colorectal cancer.
Chung YF; Eu KW; Machin D; Ho JM; Nyam DC; Leong AF; Ho YH; Seow-Choen F
Br J Surg; 1998 Sep; 85(9):1255-9. PubMed ID: 9752871
[TBL] [Abstract][Full Text] [Related]
9. Risk of colorectal cancer in relatives: a case control study.
Safaee A; Moghimi-Dehkordi B; Pourhoseingholi MA; Vahedi M; Maserat E; Ghiasi S; Fatemi SR; Zali MR
Indian J Cancer; 2010; 47(1):27-30. PubMed ID: 20071786
[TBL] [Abstract][Full Text] [Related]
10. A scoring system for the strength of a family history of colorectal cancer.
Church JM
Dis Colon Rectum; 2005 May; 48(5):889-96. PubMed ID: 15785893
[TBL] [Abstract][Full Text] [Related]
11. [Screening practices and familial antecedents of colorectal cancer. Survey with a voluntary population].
Eisinger F; Giordanella JP; Didelot R; Julian-Reynier C; Moatti JP; Sobol H; Seitz JF
Gastroenterol Clin Biol; 1996; 20(8-9):627-32. PubMed ID: 8977808
[TBL] [Abstract][Full Text] [Related]
12. Different distribution of Dukes' stage between proximal and distal colorectal cancer.
Ikeda Y; Akagi K; Kinoshita J; Abe T; Miyazaki M; Mori M; Sugimachi K
Hepatogastroenterology; 2002; 49(48):1535-7. PubMed ID: 12397728
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study of colorectal cancer patients in King Chulalongkorn Memorial Hospital.
Kullavanijaya P; Rerknimitr R; Amornrattanakosol J
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S85-90. PubMed ID: 12188457
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
15. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
[TBL] [Abstract][Full Text] [Related]
16. Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.
Skelly MM; Troy A; Duffy MJ; Mulcahy HE; Duggan C; Connell TG; O'Donoghue DP; Sheahan K
Clin Cancer Res; 1997 Oct; 3(10):1837-40. PubMed ID: 9815571
[TBL] [Abstract][Full Text] [Related]
17. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma.
Purdie CA; Piris J
Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity of TP53 is not correlated with clinicopathological variables in sporadic colorectal carcinomas.
González-Aguilera JJ; Herrero MP; Maillo C; Moreno-Azcoita M; Fernández-Peralta AM
Anticancer Res; 1999; 19(2A):1325-9. PubMed ID: 10368694
[TBL] [Abstract][Full Text] [Related]
19. Mismatch repair protein MSH2, cytokeratin 18 and cytokeratin 20 expression: clinicopathological correlation and prognostic value in colorectal cancer patients.
González JJ; Bernardo CG; Sanz L; Fresno MF; Barbón E; Noval JG; Martínez E
Hepatogastroenterology; 2007 Dec; 54(80):2266-71. PubMed ID: 18265645
[TBL] [Abstract][Full Text] [Related]
20. The cytogenetic identification of high risk members in colorectal cancer families.
Jyothish B; Ankathil R; Chandini R; Vinodkumar B; Nayar GS; Roy DD; Madhavan J; Nair MK
Neoplasma; 1997; 44(4):258-62. PubMed ID: 9473780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
